The pathophysiology of thrombocytopenia in chronic liver disease

O Mitchell, DM Feldman, M Diakow… - … medicine: evidence and …, 2016 - Taylor & Francis
Thrombocytopenia is the most common hematological abnormality encountered in patients
with chronic liver disease (CLD). In addition to being an indicator of advanced disease and …

Soluble transferrin receptor for the evaluation of erythropoiesis and iron status

Y Beguin - Clinica chimica acta, 2003 - Elsevier
Iron transport in the plasma is carried out by transferrin, which donates iron to cells through
its interaction with a specific membrane receptor, the transferrin receptor (TfR). A soluble …

Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans

PJ Stohlawetz, L Dzirlo, N Hergovich… - Blood, The Journal …, 2000 - ashpublications.org
A recent study in dogs suggested that erythropoietin (EPO) not only promotes the synthesis
of increased numbers of reticulated platelets but that these newly produced platelets are …

Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patients

Y Beguin - Haematologica, 2002 - haematologica.org
BACKGROUND AND OBJECTIVES: The majority of cancer patients suffer from chronic
anemia. While recombinant human erythropoietin (rHuEPO) offers many of the advantages …

Platelet parameters in women with iron deficiency anemia.

G Kadikoylu, I Yavasoglu, Z Bolaman… - Journal of the national …, 2006 - ncbi.nlm.nih.gov
BACKGROUND: In iron deficiency anemia (IDA), several changes in platelets have been
reported. Therefore, a relationship between iron metabolism and thrombopoiesis should be …

Iron deficiency alters megakaryopoiesis and platelet phenotype independent of thrombopoietin

R Evstatiev, A Bukaty, K Jimenez… - American journal of …, 2014 - Wiley Online Library
Iron deficiency is a common cause of reactive thrombocytosis, however, the exact pathways
have not been revealed. Here we aimed to study the mechanisms behind iron deficiency …

Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis

E Streja, CP Kovesdy, S Greenland, JD Kopple… - American Journal of …, 2008 - Elsevier
BACKGROUND: High doses of human recombinant erythropoietin (rHuEPO) to achieve
hemoglobin levels greater than 13 g/dL in patients with chronic kidney disease appear to be …

Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805

F Baffert, CH Régnier, A De Pover… - Molecular cancer …, 2010 - AACR
The recent discovery of an acquired activating point mutation in JAK2, substituting valine at
amino acid position 617 for phenylalanine, has greatly improved our understanding of the …

New agents that stimulate erythropoiesis

HF Bunn - Blood, 2007 - ashpublications.org
Recombinant human erythropoietin (rhEpo) has proven to be remarkably safe and effective
for treatment of anemias, primarily those secondary to renal disease and malignancy …

Platelet counts in adults with iron deficiency anemia

I Kuku, E Kaya, S Yologlu, R Gokdeniz, A Baydin - Platelets, 2009 - Taylor & Francis
In adults with iron deficiency anemia (IDA), abnormal platelet counts were seen in several
studies. However we retrospectively examined the clinical records of a larger number of …